Dana C. Matthews
Australian National University(AU)Velindre Cancer Centre(GB)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Hematopoietic Stem Cell Transplantation, Monoclonal and Polyclonal Antibodies Research, Lymphoma Diagnosis and Treatment, Acute Lymphoblastic Leukemia research
Most-Cited Works
- → Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow Support(1993)650 cited
- → Bone Marrow Transplantation for Sickle Cell Disease(1996)624 cited
- → Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas(1995)432 cited
- → Phase I Study of 131I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome(1999)300 cited
- → Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.(1998)290 cited
- → A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas(2000)